Description

The Diabetes Autoantibody Panel is a specialized blood test used to detect the presence of specific autoantibodies that indicate type 1 diabetes or a risk of developing it in the future. These autoantibodies are markers of autoimmune activity where the body’s immune system mistakenly attacks the insulin-producing beta cells in the pancreas.

Purpose of the Test

  • Diagnose type 1 diabetes, especially in individuals with atypical symptoms
  • Distinguish between type 1 and type 2 diabetes
  • Identify risk of type 1 diabetes in at-risk individuals (e.g., those with a family history)
  • Assess individuals with latent autoimmune diabetes in adults (LADA), a slower-onset form of type 1 diabetes often misdiagnosed as type 2

Autoantibodies Tested in This Panel

1. Islet Cell Cytoplasmic Autoantibodies (ICA)

  • Target pancreatic islet cells
  • Present in ~70-80% of individuals with new-onset type 1 diabetes

2. Glutamic Acid Decarboxylase Autoantibodies (GADA or anti-GAD)

  • Target the enzyme GAD found in beta cells
  • Often present in both children and adults with autoimmune diabetes

3. Insulinoma-Associated-2 Autoantibodies (IA-2A)

  • Target a protein (IA-2) involved in insulin secretion
  • Often seen in newly diagnosed cases of type 1 diabetes

4. Insulin Autoantibodies (IAA)

  • Target insulin itself
  • Common in young children with type 1 diabetes, especially before insulin therapy begins

What the Results Can Show

  • Positive for one or more antibodies: Indicates autoimmune activity against pancreatic beta cells and supports a diagnosis of type 1 diabetes or high risk for developing it.
  • Negative for all antibodies: More likely to be type 2 diabetes or another non-autoimmune form of diabetes.
  • Antibodies may be present years before symptoms of type 1 diabetes appear.

Benefits of the Test

  • Clarifies diagnosis: Helpful in cases where symptoms of type 1 and type 2 diabetes overlap
  • Enables early monitoring: If detected early in high-risk individuals, it allows for proactive management
  • Guides treatment: Type 1 diabetes requires insulin therapy, while type 2 may respond to lifestyle changes or oral medications

Fasting Requirements

  • Fasting is not required for this test

Who Should Consider This Test?

  • Individuals with new-onset diabetes under age 30
  • Adults with diabetes who are not responding well to oral medications
  • People with a family history of type 1 diabetes
  • Children or siblings of individuals with type 1 diabetes as part of screening or clinical studies